177 related articles for article (PubMed ID: 18827906)
1. Drug-eluting stents in the management of peripheral arterial disease.
Bosiers M; Cagiannos C; Deloose K; Verbist J; Peeters P
Vasc Health Risk Manag; 2008; 4(3):553-9. PubMed ID: 18827906
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel-eluting stents for the treatment of femoropopliteal arterial stenoses: focus on the Zilver PTX drug-eluting peripheral stent.
Moukarbel GV; Burket MW
Expert Rev Med Devices; 2015 Mar; 12(2):157-62. PubMed ID: 25418344
[TBL] [Abstract][Full Text] [Related]
3. Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia.
Martens JM; Knippenberg B; Vos JA; de Vries JP; Hansen BE; van Overhagen H;
J Vasc Surg; 2009 Sep; 50(3):687-9. PubMed ID: 19700099
[TBL] [Abstract][Full Text] [Related]
4. Peripheral drug-eluting technology.
Franzone A; Stabile E; Trimarco B; Esposito G
Cardiol Clin; 2015 Feb; 33(1):151-62. PubMed ID: 25439337
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stents for treatment of focal infrapopliteal lesions.
Rastan A; Noory E; Zeller T
Vasa; 2012 Mar; 41(2):90-5. PubMed ID: 22403126
[TBL] [Abstract][Full Text] [Related]
6. Role of stents, drug-eluting stents, and stent-grafts in treatment of infrainguinal arterial disease.
Tang GL; Morasch MD
Semin Vasc Surg; 2007 Mar; 20(1):37-41. PubMed ID: 17386362
[TBL] [Abstract][Full Text] [Related]
7. Transluminal stenting for femoropopliteal occlusive disease: analysis of restenosis by serial arteriography.
Bui TD; Gordon IL; Nguyen T; Fujitani RM; Wilson SE; Conroy RC
Ann Vasc Surg; 2006 Mar; 20(2):200-8. PubMed ID: 16555031
[TBL] [Abstract][Full Text] [Related]
8. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
[TBL] [Abstract][Full Text] [Related]
9. The potential role of DES in peripheral in-stent restenosis.
Zeller T; Macharzina R; Tepe G
J Cardiovasc Surg (Torino); 2010 Aug; 51(4):561-5. PubMed ID: 20671640
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of infrapopliteal drug-eluting stents: a meta-analysis of randomized controlled trials.
Katsanos K; Spiliopoulos S; Diamantopoulos A; Karnabatidis D; Sabharwal T; Siablis D
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):645-58. PubMed ID: 23435741
[TBL] [Abstract][Full Text] [Related]
11. One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
Bosiers M; Callaert J; Keirse K; Hendriks JMH; Peeters P; Verbist J; Maene L; Beelen R; Deloose K
J Endovasc Ther; 2017 Jun; 24(3):311-316. PubMed ID: 28351310
[TBL] [Abstract][Full Text] [Related]
12. Drug eluting balloons.
Diehm NA; Hoppe H; Do DD
Tech Vasc Interv Radiol; 2010 Mar; 13(1):59-63. PubMed ID: 20123434
[TBL] [Abstract][Full Text] [Related]
13. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting balloons for treatment of SFA and popliteal disease - A review of current status.
van den Berg JC
Eur J Radiol; 2017 Jun; 91():106-115. PubMed ID: 28629556
[TBL] [Abstract][Full Text] [Related]
15. Evolving modalities for femoropopliteal interventions.
Ansel GM; Lumsden AB
J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and meta-analysis of additional technologies to enhance angioplasty for infrainguinal peripheral arterial occlusive disease.
Simpson EL; Michaels JA; Thomas SM; Cantrell AJ
Br J Surg; 2013 Aug; 100(9):1128-37. PubMed ID: 23842827
[TBL] [Abstract][Full Text] [Related]
17. Are drug-eluting stents the future of SFA treatment?
Bosiers M; Deloose K; Keirse K; Verbist J; Peeters P
J Cardiovasc Surg (Torino); 2010 Feb; 51(1):115-9. PubMed ID: 20081767
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit.
Siablis D; Karnabatidis D; Katsanos K; Kagadis GC; Kraniotis P; Diamantopoulos A; Tsolakis J
J Endovasc Ther; 2007 Apr; 14(2):241-50. PubMed ID: 17484536
[TBL] [Abstract][Full Text] [Related]
19. Two-year results after directional atherectomy of infrapopliteal arteries with the SilverHawk device.
Zeller T; Sixt S; Schwarzwälder U; Schwarz T; Frank U; Bürgelin K; Pochert V; Müller C; Noory E; Krankenberg H; Hauswald K; Neumann FJ; Rastan A
J Endovasc Ther; 2007 Apr; 14(2):232-40. PubMed ID: 17484535
[TBL] [Abstract][Full Text] [Related]
20. Update management below knee intervention.
Bosiers M; Deloose K; Verbist J; Peeters P
Minerva Cardioangiol; 2009 Feb; 57(1):117-29. PubMed ID: 19202523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
